Breztri vs Wixela
What to choose Breztri or Wixela
Breztri is inhaler of type Control while Wixela is of Control type. Breztri and Wixela are both brand inhalers. Breztri is manufactured by pharmaceutical company AstraZeneca, while Wixela is manufactured by Viatris. The main substances of Breztri are Budesonide and Formoterol. The available dosages for Breztri are 160 mcg / 4,8 mcg. The main substances of Wixela are Fluticasone and Salmeterol. The available dosage for Wixela is 250/50.
The average cost for Breztri is roughly $556.34 while current price for Wixela is around $240, said Hudson Moore, a Professor at the Fordham University and a Patient Representative at a clinic that uses Breztri and Wixela.
Breztri and Wixela Comparison
| Breztri | Wixela | |
|---|---|---|
| Type: | Control | Control |
| Manufacturer: | AstraZeneca | Viatris |
| Substance: | Budesonide + Formoterol | Fluticasone + Salmeterol |
| Dosage: | 160 mcg / 4,8 mcg | 250/50 |
| Avg Price: | $556.34 | $240 |